Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Scott Sutton

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Association between Haloperidol use and Risk of Rheumatoid ArthritisVidya L Ambati, Tammy H Cummings, Praveen Yerramothu, et al.
Journal of Thrombosis and Thrombolysis|May 23, 2023
Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrateS Scott Sutton, Joseph Magagnoli, Tammy H Cummings, et al.
Medcomm - Future Medicine|February 1, 2024
Association between Haloperidol use and Risk of Rheumatoid ArthritisVidya L Ambati, Tammy H Cummings, Praveen Yerramothu, et al.
Journal of Emergencies, Trauma, and Shock|November 11, 2021
Abstracts for the 39<sup>th</sup> Emergencies in Medicine ConferenceSukaina Ali Alali, Tinh Le, M DeVogelaere, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 12, 2026
Evaluating the Impact of Blood Brain Barrier-Penetrant ACE Inhibitors on HIV-Associated Neurocognitive DisordersTammy H Cummings, Joseph Magagnoli, Sasha Sikirzhytskaya, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among patients with human immunodeficiency virusTammy H Cummings, Joseph Magagnoli, Aliaksandra Sikirzhytskaya, et al.
AIDS (London, England)|September 9, 2024
Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among people with HIVTammy H Cummings, Joseph Magagnoli, Aliaksandra Sikirzhytskaya, et al.
Medcomm - Future Medicine|September 11, 2023
Anti-HIV Drugs Reduce Risk of Prediabetes and Progression to Type 2 Diabetes in HIV-Infected PatientsJoseph Magagnoli, Felipe Pereira, Siddharth Narendran, et al.
Annals of Family Medicine|March 12, 2014
Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and deathGowtham A Rao, Joshua R Mann, Azza Shoaibi, et al.
The Annals of Pharmacotherapy|April 13, 2012
Role of raltegravir in HIV-1 managementKristina E E Rokas, P Brandon Bookstaver, Caitlin L Shamroe, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Association between Haloperidol use and Risk of Rheumatoid ArthritisVidya L Ambati, Tammy H Cummings, Praveen Yerramothu, et al.
Journal of Thrombosis and Thrombolysis|May 23, 2023
Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrateS Scott Sutton, Joseph Magagnoli, Tammy H Cummings, et al.
Medcomm - Future Medicine|February 1, 2024
Association between Haloperidol use and Risk of Rheumatoid ArthritisVidya L Ambati, Tammy H Cummings, Praveen Yerramothu, et al.
Journal of Emergencies, Trauma, and Shock|November 11, 2021
Abstracts for the 39<sup>th</sup> Emergencies in Medicine ConferenceSukaina Ali Alali, Tinh Le, M DeVogelaere, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 12, 2026
Evaluating the Impact of Blood Brain Barrier-Penetrant ACE Inhibitors on HIV-Associated Neurocognitive DisordersTammy H Cummings, Joseph Magagnoli, Sasha Sikirzhytskaya, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among patients with human immunodeficiency virusTammy H Cummings, Joseph Magagnoli, Aliaksandra Sikirzhytskaya, et al.
AIDS (London, England)|September 9, 2024
Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among people with HIVTammy H Cummings, Joseph Magagnoli, Aliaksandra Sikirzhytskaya, et al.
Medcomm - Future Medicine|September 11, 2023
Anti-HIV Drugs Reduce Risk of Prediabetes and Progression to Type 2 Diabetes in HIV-Infected PatientsJoseph Magagnoli, Felipe Pereira, Siddharth Narendran, et al.
Annals of Family Medicine|March 12, 2014
Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and deathGowtham A Rao, Joshua R Mann, Azza Shoaibi, et al.
The Annals of Pharmacotherapy|April 13, 2012
Role of raltegravir in HIV-1 managementKristina E E Rokas, P Brandon Bookstaver, Caitlin L Shamroe, et al.
Pageof 8